Treatment of essential hypertension does not normalize capillary rarefaction
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/17750 |
Resumo: | OBJECTIVES: To determine if capillary rarefaction persists when hypertension is treated with angiotensin converting enzyme inhibitor, thiazidic diuretic and/or beta-blocker, and to identify which microcirculatory alterations (structural and functional) persist after anti-hypertensive treatment. METHODS: We evaluated 28 well-controlled essential hypertensive patients and 19 normotensive subjects. Nailfold videocapillaroscopy examination of the fourth finger of the left hand was used to determine the functional capillary densities at baseline, during post-occlusive hyperemia, and after venous congestion. Capillary loop diameters (afferent, apical and efferent) and red blood cell velocity were also quantified. RESULTS: Compared with normotensive subjects, hypertensive patients showed lower mean functional capillary density at baseline (25.1±1.4 vs. 33.9±1.9 cap/mm², p |
id |
USP-19_ae53963c7e190f15d41403d6e6264195 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/17750 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Treatment of essential hypertension does not normalize capillary rarefaction Anti-hypertensive drugsMicrocirculationMicrovascular dysfunctionVideocapillaroscopy OBJECTIVES: To determine if capillary rarefaction persists when hypertension is treated with angiotensin converting enzyme inhibitor, thiazidic diuretic and/or beta-blocker, and to identify which microcirculatory alterations (structural and functional) persist after anti-hypertensive treatment. METHODS: We evaluated 28 well-controlled essential hypertensive patients and 19 normotensive subjects. Nailfold videocapillaroscopy examination of the fourth finger of the left hand was used to determine the functional capillary densities at baseline, during post-occlusive hyperemia, and after venous congestion. Capillary loop diameters (afferent, apical and efferent) and red blood cell velocity were also quantified. RESULTS: Compared with normotensive subjects, hypertensive patients showed lower mean functional capillary density at baseline (25.1±1.4 vs. 33.9±1.9 cap/mm², pHospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2008-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1775010.1590/S1807-59322008000500008Clinics; Vol. 63 No. 5 (2008); 613-618 Clinics; v. 63 n. 5 (2008); 613-618 Clinics; Vol. 63 Núm. 5 (2008); 613-618 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/17750/19815Penna, Guilherme Loures de AraújoGarbero, Rodrigo de FreitasNeves, Mario FritschOigman, WilleBottino, Daniel AlexandreBouskela, Elieteinfo:eu-repo/semantics/openAccess2012-05-22T18:30:32Zoai:revistas.usp.br:article/17750Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:30:32Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Treatment of essential hypertension does not normalize capillary rarefaction |
title |
Treatment of essential hypertension does not normalize capillary rarefaction |
spellingShingle |
Treatment of essential hypertension does not normalize capillary rarefaction Penna, Guilherme Loures de Araújo Anti-hypertensive drugs Microcirculation Microvascular dysfunction Videocapillaroscopy |
title_short |
Treatment of essential hypertension does not normalize capillary rarefaction |
title_full |
Treatment of essential hypertension does not normalize capillary rarefaction |
title_fullStr |
Treatment of essential hypertension does not normalize capillary rarefaction |
title_full_unstemmed |
Treatment of essential hypertension does not normalize capillary rarefaction |
title_sort |
Treatment of essential hypertension does not normalize capillary rarefaction |
author |
Penna, Guilherme Loures de Araújo |
author_facet |
Penna, Guilherme Loures de Araújo Garbero, Rodrigo de Freitas Neves, Mario Fritsch Oigman, Wille Bottino, Daniel Alexandre Bouskela, Eliete |
author_role |
author |
author2 |
Garbero, Rodrigo de Freitas Neves, Mario Fritsch Oigman, Wille Bottino, Daniel Alexandre Bouskela, Eliete |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Penna, Guilherme Loures de Araújo Garbero, Rodrigo de Freitas Neves, Mario Fritsch Oigman, Wille Bottino, Daniel Alexandre Bouskela, Eliete |
dc.subject.por.fl_str_mv |
Anti-hypertensive drugs Microcirculation Microvascular dysfunction Videocapillaroscopy |
topic |
Anti-hypertensive drugs Microcirculation Microvascular dysfunction Videocapillaroscopy |
description |
OBJECTIVES: To determine if capillary rarefaction persists when hypertension is treated with angiotensin converting enzyme inhibitor, thiazidic diuretic and/or beta-blocker, and to identify which microcirculatory alterations (structural and functional) persist after anti-hypertensive treatment. METHODS: We evaluated 28 well-controlled essential hypertensive patients and 19 normotensive subjects. Nailfold videocapillaroscopy examination of the fourth finger of the left hand was used to determine the functional capillary densities at baseline, during post-occlusive hyperemia, and after venous congestion. Capillary loop diameters (afferent, apical and efferent) and red blood cell velocity were also quantified. RESULTS: Compared with normotensive subjects, hypertensive patients showed lower mean functional capillary density at baseline (25.1±1.4 vs. 33.9±1.9 cap/mm², p |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/17750 10.1590/S1807-59322008000500008 |
url |
https://www.revistas.usp.br/clinics/article/view/17750 |
identifier_str_mv |
10.1590/S1807-59322008000500008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/17750/19815 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 63 No. 5 (2008); 613-618 Clinics; v. 63 n. 5 (2008); 613-618 Clinics; Vol. 63 Núm. 5 (2008); 613-618 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222753474740224 |